These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31191536)

  • 21. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
    Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
    Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines.
    Kim Y; Kim JE; Lee DY; Choi JU; Park JS; Lee HK; Choi SU; Park S; Park CH
    Anticancer Res; 2023 Aug; 43(8):3419-3427. PubMed ID: 37500142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.
    Boice M; Salloum D; Mourcin F; Sanghvi V; Amin R; Oricchio E; Jiang M; Mottok A; Denis-Lagache N; Ciriello G; Tam W; Teruya-Feldstein J; de Stanchina E; Chan WC; Malek SN; Ennishi D; Brentjens RJ; Gascoyne RD; Cogné M; Tarte K; Wendel HG
    Cell; 2016 Oct; 167(2):405-418.e13. PubMed ID: 27693350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the BTLA-HVEM complex in the pathogenesis of breast cancer.
    Hu X
    Breast Cancer; 2024 May; 31(3):358-370. PubMed ID: 38483699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The multiple faces of CD5.
    Burgueño-Bucio E; Mier-Aguilar CA; Soldevila G
    J Leukoc Biol; 2019 May; 105(5):891-904. PubMed ID: 30676652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells.
    Huang Y; Zhao Y; Ran X; Wang C
    Mol Med Rep; 2014 Mar; 9(3):813-8. PubMed ID: 24366217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of BTLA/HVEM network in development of gastric cancer.
    Azarafza M; Tehrani M; Valadan R; Maleki I; Mohammad Mehdi Ghaffari-Hamedani S; Ghanadan A; Alizadeh-Navaei R; Ajami A
    Hum Immunol; 2022; 83(8-9):637-644. PubMed ID: 35914980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
    Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
    J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BTLA-HVEM complex - The future of cancer immunotherapy.
    Wojciechowicz K; Spodzieja M; Wardowska A
    Eur J Med Chem; 2024 Mar; 268():116231. PubMed ID: 38387336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BTLA
    Simon T; Bromberg JS
    Immunity; 2016 Nov; 45(5):956-958. PubMed ID: 27851922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.
    De Trez C; Ware CF
    Cytokine Growth Factor Rev; 2008; 19(3-4):277-84. PubMed ID: 18511331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.
    Blaize G; Daniels-Treffandier H; Aloulou M; Rouquié N; Yang C; Marcellin M; Gador M; Benamar M; Ducatez M; Song KD; Burlet-Schiltz O; Saoudi A; Love PE; Fazilleau N; Gonzalez de Peredo A; Lesourne R
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12969-12979. PubMed ID: 32434911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
    Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
    Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation - design, synthesis and biological evaluation.
    Kuncewicz K; Bojko M; Battin C; Karczyńska A; Sieradzan A; Sikorska E; Węgrzyn K; Wojciechowicz K; Wardowska A; Steinberger P; Rodziewicz-Motowidło S; Spodzieja M
    Biomed Pharmacother; 2023 Sep; 165():115161. PubMed ID: 37473684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and Significance of BTLA and Its Ligand HVEM in Patients with Chronic Myelomonocytic Leukemia].
    Li C; Geng SX; Li MM; Su F; Chen XM; Deng CX; Huang X; Lai PL; Weng JY; DU X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):56-62. PubMed ID: 32027253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.
    Cheung TC; Humphreys IR; Potter KG; Norris PS; Shumway HM; Tran BR; Patterson G; Jean-Jacques R; Yoon M; Spear PG; Murphy KM; Lurain NS; Benedict CA; Ware CF
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13218-23. PubMed ID: 16131544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
    Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
    J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.
    Pasero C; Truneh A; Olive D
    Curr Mol Med; 2009 Sep; 9(7):911-27. PubMed ID: 19860669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD160 and BTLA: LIGHTs out for CD4+ T cells.
    Kaye J
    Nat Immunol; 2008 Feb; 9(2):122-4. PubMed ID: 18204424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.